Vivanza Biosciences Q3 Results
- BSE: 530057
- NSE: -
- ISIN: INE984E01035
- Sector: Biotechnology & Drugs
BSE
2.35
-0.06 (-2.49%)
-0.06 (-2.49%)Volume33.31 K
Updated: Fri 13 Jun, 2025 | 15:29:58
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Vivanza Biosciences Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 1.50 | 3.00 | -49.99% | 6.56 | -77.13% |
| Selling/ General/ Admin Expenses Total | 0.13 | 0.14 | -3.20% | 0.11 | 17.92% |
| Depreciation/ Amortization | 0.00 | 0.00 | 0.00% | 0.00 | 485.71% |
| Other Operating Expenses Total | 0.13 | 0.04 | 236.41% | 0.12 | 9.05% |
| Total Operating Expense | 1.38 | 2.90 | -52.33% | 6.27 | -77.99% |
| Operating Income | 0.12 | 0.11 | 14.46% | 0.29 | -58.56% |
| Net Income Before Taxes | 0.04 | 0.02 | 180.00% | 0.21 | -78.93% |
| Net Income | 0.04 | 0.02 | 180.00% | 0.21 | -78.93% |
| Diluted Normalized EPS | 0.01 | 0.00 | 179.64% | 0.05 | -78.30% |